Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
22.75
+1.41 (6.58%)
At close: Oct 15, 2026, 4:00 PM EDT
22.88
+0.13 (0.59%)
After-hours: Oct 15, 2026, 7:36 PM EDT
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $678.20M in the quarter ending June 30, 2026, a decrease of -4.52%. This brings the company's revenue in the last twelve months to $2.68B, down -2.09% year-over-year. In the year 2025, Fortrea Holdings had annual revenue of $2.72B with 1.00% growth. That makes Fortrea Holdings the 4,096th largest company in the world by revenue and 1,122nd in the United States.
Revenue (ttm)
$2.68B
Revenue Growth
-2.09%
P/S Ratio
0.81
Revenue / Employee
$191,179
Employees
14,000
Market Cap
2.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.72B | 27.00M | 1.00% |
| Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
| Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
| Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harmony Biosciences Holdings | 959.90M |
| Novavax | 413.80M |
| Aurinia Pharmaceuticals | 311.51M |
| Vericel | 306.30M |
| Viridian Therapeutics | 71.13M |
| Recursion Pharmaceuticals | 54.86M |
| Celldex Therapeutics | 158.00K |
FTRE News
- 20 hours ago - Deutsche upgrades Fortrea to Buy on ‘fundamental inflection point’ - TheFly
- 20 hours ago - Fortrea upgraded to Buy from Hold at Deutsche Bank - TheFly
- 6 days ago - Fortrea price target raised to $15.50 from $13 at BofA - TheFly
- 9 days ago - Fortrea upgraded to Overweight from Equal Weight at Barclays - TheFly
- 10 days ago - Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call - GlobeNewsWire
- 15 days ago - Fortrea initiated with a Neutral at UBS - TheFly
- 4 weeks ago - Fortrea Holdings Transcript: 2026 Global Healthcare Conference - Transcripts
- 5 weeks ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire